About PulseVet
PulseVet is a company based in Alpharetta (United States) founded in 2009 was acquired by Zomedica in October 2021. PulseVet offers products and services including PulseVet Device, X-Trode, and Equine Trode Set. PulseVet operates in a competitive market with competitors including Welch Allyn, Kubanda Cryotherapy, IntegriMedical, Zibo Kezhixing Robot and Vetbiolix, among others.
- Headquarter Alpharetta, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PulseVet
PulseVet offers a comprehensive portfolio of products and services, including PulseVet Device, X-Trode, and Equine Trode Set.
High-energy shock wave therapy for animal pain relief and healing.
Enhances comfort in shock wave treatments for various animal conditions.
Custom hand pieces for treating equine injuries and wounds.
Funding Insights of PulseVet
Detailed funding history for PulseVet
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PulseVet
PulseVet has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Zomedica, Thompson Street Capital Partners and Branford Castle Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity firm focused on middle-market business investments.
|
Locked | Locked | Locked | |
|
Branford Castle Partners is engaged in private market investments.
|
Locked | Locked | Locked | |
|
Diagnostics and pharmaceuticals for companion animals are developed.
|
Locked | Locked | Locked |
Investor details for PulseVet
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PulseVet
Investment portfolio details for PulseVet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PulseVet
Detailed financials for PulseVet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pulsevet Comparisons
Peer comparison for PulseVet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PulseVet
PulseVet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welch Allyn, Kubanda Cryotherapy, IntegriMedical, Zibo Kezhixing Robot and Vetbiolix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides smart beds, patient monitoring, and care communications for healthcare facilities.
|
|
| Locked | Locked | Locked |
Cryotherapy devices for treating pet cancer are provided.
|
|
| Locked | Locked | Locked |
Needle-free injection systems for pets are developed.
|
|
| Locked | Locked | Locked |
Developer of surgical devices for treating multiple diseases in humans & animals
|
|
| Locked | Locked | Locked |
Develops first-in-class drugs for pet conditions including periodontitis and osteoarthritis.
|
|
| Locked | Locked | Locked |
Resorbable surgical implants are developed for orthopedics and urology.
|
Detailed competitors of PulseVet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pulsevet
Complete news archive for PulseVet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PulseVet
PulseVet was founded in 2009.
PulseVet is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Adrian Lock is the current CEO of PulseVet.
PulseVet was founded in 2009 in Alpharetta, United States. Regenerative medicines and pain management therapies are developed for equine and small animals within the veterinary sector. Operations focus on non-invasive treatments, including the ProPulse device, which applies high-energy focused sound waves to address pain and lameness. Services target therapeutic applications in animal health across the region.
PulseVet's top competitors include Kubanda Cryotherapy, IntegriMedical and Jeshron Biotech Solutions.
PulseVet offers PulseVet Device, X-Trode, and Equine Trode Set.
PulseVet has 3 investors. Key investors include Zomedica, Thompson Street Capital Partners, and Branford Castle Partners.